Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey.

Philipp MT, Lobet Y, Bohm RP Jr, Roberts ED, Dennis VA, Gu Y, Lowrie RC Jr, Desmons P, Duray PH, England JD, Hauser P, Piesman J, Xu K.

Vaccine. 1997 Dec;15(17-18):1872-87.

PMID:
9413097
2.

Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi.

Chang YF, Appel MJ, Jacobson RH, Shin SJ, Harpending P, Straubinger R, Patrican LA, Mohammed H, Summers BA.

Infect Immun. 1995 Sep;63(9):3543-9.

3.

Vaccination against lyme disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses.

Chang Y, Novosol V, McDonough SP, Chang CF, Jacobson RH, Divers T, Quimby FW, Shin S, Lein DH.

Vaccine. 1999 Oct 14;18(5-6):540-8.

PMID:
10519945
4.

Inhibition of Borrelia burgdorferi-tick interactions in vivo by outer surface protein A antibody.

Pal U, Montgomery RR, Lusitani D, Voet P, Weynants V, Malawista SE, Lobet Y, Fikrig E.

J Immunol. 2001 Jun 15;166(12):7398-403.

5.
6.

Protection against tick-transmitted Lyme disease in dogs vaccinated with a multiantigenic vaccine.

Straubinger RK, Dharma Rao T, Davidson E, Summers BA, Jacobson RH, Frey AB.

Vaccine. 2001 Oct 12;20(1-2):181-93.

PMID:
11567763
7.
8.
10.

Demonstration of the ability of a canine Lyme vaccine to reduce the incidence of histological synovial lesions following experimentally-induced canine Lyme borreliosis.

Grosenbaugh DA, Rissi DR, Krimer PM.

Vet Immunol Immunopathol. 2016 Nov 1;180:29-33. doi: 10.1016/j.vetimm.2016.08.014. Epub 2016 Aug 31.

PMID:
27692092
12.
14.

Protection of dogs from Lyme disease with a vaccine containing outer surface protein (Osp) A, OspB, and the saponin adjuvant QS21.

Coughlin RT, Fish D, Mather TN, Ma J, Pavia C, Bulger P.

J Infect Dis. 1995 Apr;171(4):1049-52.

PMID:
7706788
15.

Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites.

Gern L, Rais O, Capiau C, Hauser P, Lobet Y, Simoen E, Voet P, PĂȘtre J.

Immunol Lett. 1994 Mar;39(3):249-58.

PMID:
8034340
16.

Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.

de Silva AM, Telford SR 3rd, Brunet LR, Barthold SW, Fikrig E.

J Exp Med. 1996 Jan 1;183(1):271-5.

18.

OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks.

Tsao J, Barbour AG, Luke CJ, Fikrig E, Fish D.

Vector Borne Zoonotic Dis. 2001 Spring;1(1):65-74.

PMID:
12653137
19.

An OspA-based DNA vaccine protects mice against infection with Borrelia burgdorferi.

Luke CJ, Carner K, Liang X, Barbour AG.

J Infect Dis. 1997 Jan;175(1):91-7.

PMID:
8985201
20.

Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.

LaFleur RL, Dant JC, Wasmoen TL, Callister SM, Jobe DA, Lovrich SD, Warner TF, Abdelmagid O, Schell RF.

Clin Vaccine Immunol. 2009 Feb;16(2):253-9. doi: 10.1128/CVI.00373-08. Epub 2008 Dec 3.

Supplemental Content

Support Center